Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Mets Rumors

Mets Claim Robert Stock, Expected To Activate Michael Conforto Wednesday

By | at

7:20 pm: Conforto’s absence is indeed related to contact tracing protocols at Syracuse, the club announced. He has tested negative for COVID-19 and is expected to be reinstated in advance of tomorrow evening’s game against the Braves.

5:17 pm: The Mets announced they’ve claimed right-hander Robert Stock off waivers from the Cubs. He’s been optioned to Triple-A Syracuse. Infielder Brandon Drury was also optioned, while catcher Patrick Mazeika was recalled.

Chicago just selected Stock to the big league roster last week. Generally a reliever, he made a four-inning spot start last Wednesday that ironically came against his new team. The 31-year-old allowed five runs on six walks while only striking out three, but the Mets were evidently intrigued by their then-opponent. After the Cubs designated him for assignment last weekend, New York put in a claim.

Stock has pitched to a 4.12 ERA with very strong strikeout and walk rates (30.5% and 4.9%, respectively) in Triple-A this year. He can be optioned for the rest of this season, so he’ll offer the Mets a flexible depth piece on the pitching staff.

Notably, the Mets did not reinstate outfielder Michael Conforto from the IL today. General manager Zack Scott told reporters (including Anthony DiComo of MLB.com) earlier in the day that the All-Star outfielder would return tonight. Notably, the Syracuse Mets, where Conforto had been on a rehab assignment, have since announced they’re dealing with a COVID-19 situation. It’s not clear if Conforto not being reinstated is related in any way.

Mets’ Joey Lucchesi To Undergo Tommy John Surgery

By | at

Mets left-hander Joey Lucchesi has been diagnosed with a complete tear of the UCL in his throwing elbow, Laura Albanese of Newsday was among those to relay (Twitter link). He’ll undergo Tommy John surgery this week. Obviously, Lucchesi is done for the rest of 2021 and will miss most or all of the 2022 campaign.

New York acquired the 28-year-old from the Padres last winter as part of the three-team deal that sent Joe Musgrove to San Diego. He made eleven appearances (eight starts) in his debut campaign with the Mets, pitching to a 4.46 ERA but posting stronger underlying numbers. Lucchesi punched out an above-average 26.1% of opposing hitters while walking only 7.0%. Those positive strikeout and walk rates contributed to a much better 3.74 SIERA, his lowest mark since his 2018 rookie campaign with the Friars (when he posted a 3.64).

Today’s news isn’t unexpected, since Lucchesi was diagnosed with a significant UCL tear yesterday. It’s nevertheless a disappointing development for a New York staff that is still without Carlos Carrasco and Noah Syndergaard as they recover from long-term injuries. The Mets have gotten very strong work from Jacob deGrom, Marcus Stroman and Taijuan Walker this year, but David Peterson has struggled. Jerad Eickhoff, recently selected to the MLB roster, might be the favorite to assume Lucchesi’s spot in the rotation for now.

It remains to be seen whether this will mark the end of Lucchesi’s Mets tenure. New York can place him on the 60-day injured list for the remainder of the season, but players must be reinstated from the IL during the offseason. New York will have to decide whether it’s worth tendering Lucchesi a contract and carrying him on the 40-man roster all winter. He’ll eclipse three years of MLB service during his IL stint, so Lucchesi will be eligible for arbitration for the first time. If the Mets do tender him a contract with an eye toward a potential late-2022 or 2023 return, Lucchesi would be controllable through the end of the 2024 season.

Mets’ Joey Lucchesi Diagnosed With UCL Tear

By | at

10:23pm: Manager Luis Rojas acknowledged after tonight’s game that surgery is a possibility for Lucchesi but said the left-hander will receive a second opinion before making a final decision (Twitter link via Newsday’s Laura Albanese).

7:34pm: Mets left-hander Joey Lucchesi, who went on the injured list this weekend, underwent an MRI and was diagnosed with a “significant” tear in his left elbow’s ulnar collateral ligament, reports Steve Gelbs of SNY (Twitter link). The Mets haven’t formally announced an update, but any UCL tear obviously comes with the possibility of Tommy John surgery. He’ll seek a second opinion before making any decisions.

In further Mets injury news, the team announced prior to the second game of today’s doubleheader that Jeurys Familia has been placed on the injured list due to a right hip impingement. That injury comes just hours after the Mets placed righty Robert Gsellman on the 10-day injured list due to a lat strain that will reportedly sideline him for up to eight weeks. Right-hander Yennsy Diaz is up from Triple-A Syracuse to take Familia’s spot on the roster. The team has not yet provided a timeline on Familia’s injury.

Lucchesi, 28, has given the Mets 38 1/3 innings of 4.46 ERA ball with a 3.40 FIP, a 26.1 percent strikeout rate and a 7.0 percent walk rate. That’s solid production from any pitcher, let alone one who was viewed as a depth option and perhaps the sixth or seventh starting pitcher on the team’s depth chart when Spring Training commenced. That performance has certainly justified the Mets’ decision to part with catching prospect Endy Rodriguez to acquire Lucchesi from the Padres as part of the three-team, Joe Musgrove trade with the Pirates. Now, however, there are considerable doubts as to just when Lucchesi will throw his next pitch.

If Lucchesi indeed requires Tommy John surgery, the procedure is coming late enough in the 2021 season that it’ll jeopardize the majority, if not the entirety, of his 2022 season.. Tommy John procedures typically come with recovery periods in the range of 12 to 16 months, and as the Mets’ own Noah Syndergaard illustrates, a straightforward year-long recovery period is not necessarily a given.

A Tommy John procedure would put the Mets in a tough spot with Lucchesi. He’ll be arbitration-eligible for the first time this winter now that he’ll close out the current season on the 60-day injured list. Any raise will be suppressed by his current injury status, of course, but they’d still need to determine whether to dedicate a 40-man spot to him all winter and pay him a raise for the 2022 season despite the possibility that he won’t pitch at all. In that scenario, they’d again be faced with the decision of whether to again dedicate an offseason 40-man spot and likely match that salary in 2023 — most arb-eligible players who miss a whole season are re-upped at the same rate for the following year — or cut bait via a non-tender.

Obviously, the hope for the Mets, Lucchesi and their fans is that he’ll somehow be able to avoid surgery and return to the mound without going under the knife. However, the report of a “significant” tear indicates that even if surgery is avoided for now, Lucchesi is likely looking at a notable shutdown.

The loss of Lucchesi in the near-term is a blow to a Mets club that has been hit hard by injuries up and down the roster. Carlos Carrasco has still yet to pitch in 2021, owing to a hamstring tear a brief elbow issue in Spring Training, while Syndergaard’s return has been pushed back by at least six weeks due to inflammation in his surgically repaired elbow. Righty Jordan Yamamoto, meanwhile, is on the 60-day injured list due to shoulder woes.

With those injuries having taken their toll, the Mets turned to former Phillies righty Jerad Eickhoff to start the nightcap of today’s twin bill. Other options on the 40-man roster include recent waiver claim Nick Tropeano and 25-year-old prospect Thomas Szapucki, who has yet to make his MLB debut.

The Mets entered the season with a fairly impressive bit of pitching depth, but that depth has obviously been tested early and often. Given the news on Lucchesi, the setbacks in the recoveries of Syndergaard and Carrasco, and the minor injury troubles that Jacob deGrom and Taijuan Walker have faced, it wouldn’t be much of a surprise to see the Mets target rotation help on the summer trade market.

Turning to Familia, his injury places a temporary hold on what was shaping up to be a solid rebound effort. While the right-hander’s 14.3 percent walk rate has been far too high, Familiar has nevertheless pitched to a 3.63 ERA with a 23 percent strikeout rate in 22 1/3 frames. He’s also generated plenty of weak contact and induced grounders at a characteristically high 58.5 percent clip, which has helped to offset the penchant for free passes. It may not be the dominant form he displayed from 2014-18, but it’s nevertheless been a nice season for the righty.

The bullpen has been one area where the Mets haven’t been bitten too hard by the injury bug, but back-to-back losses of Gsellman and Familia now threaten to begin testing the depth on that side of the pitching staff as well. The Mets are undoubtedly thankful that deGrom was able to breeze through five innings today after his own recent injury scare, but it’s still been a rough day for the pitching staff as a whole — one that could very well accelerate the team’s efforts to add from outside the organization.

Mets Activate Jeff McNeil; Robert Gsellman Out Up To Eight Weeks

By | at

5:35pm: The outlook on Gsellman isn’t good, as SNY’s Steve Gelbs reports (via Twitter) that a tear in his lat will cause the right-hander to miss anywhere from six to eight weeks of action. That’ll sideline him well into the season’s second half.

2:19pm: As expected, the Mets activated utilityman Jeff McNeil off the 10-day IL today, so he will take Gsellman’s spot on the active roster.  McNeil has been out of action since May 17 due to a hamstring strain, and he now looks to resume his duty as New York’s regular second baseman.  The former All-Star was off to a bit of a slow start prior to his injury, with only a modest .242/.336/.374 slash line over his first 113 plate appearances.

1:20pm: The Mets will be placing right-hander Robert Gsellman on the 10-day injured list due to a right lat strain, according to SNY’s Andy Martino (via Twitter).  Gsellman last pitched on Saturday, tossing two innings as the opener in the second game of a doubleheader against the Nationals.

The injury is particularly ill-timed, as the Mets have another doubleheader today against the Braves, and then yet another doubleheader against the Phillies on Friday.  Though there is a Thursday off-day in between, the losses of both Gsellman and Joey Lucchesi to the IL within the last couple of days will leave the Mets short on pitching depth for this busy week.

Gsellman has allowed five runs over his last 4 1/3 innings of work, souring what had been a pretty solid season, out of New York’s bullpen.  The righty has a 3.71 ERA/4.47 SIERA over 26 2/3 total innings in 2021, relying on soft contact and a career-best 50.6% grounder rate to counteract a tiny 13.6% strikeout rate.  It was a nice bounce-back for Gsellman following an injury-marred 2020 that saw him post a 9.64 ERA over 14 frames.

Mets Owner Steve Cohen Discusses Luxury Tax, deGrom, Stroman

By | at

Mets owner Steve Cohen met with reporters (including Mike Puma of the New York Post and Anthony DiComo of MLB.com) yesterday to discuss the team’s outlook in advance of the July 30 trade deadline. Most notably, Cohen was asked whether he’d be willing to sign off on a midseason acquisition that pushes the team’s competitive balance tax outlay north of the first threshold of $210MM.

“It’s something to think about because there is a price to pay if you go over for the following year or the year after,” Cohen said. “I am not going to go over for a million or two million. That’s stupid, so if you are going to do it, you are going to do it, so we’ll see what’s available.”

Cohen is alluding to the escalating penalties for teams that surpass the threshold in consecutive seasons. Under the current collective bargaining agreement, a club that exceeds the lowest threshold for the first time is subject to a 20% tax on the overage. Exceeding that threshold for a second consecutive year subjects the team to a 30% tax on the overage, while the club would pay a 50% tax on excess expenditures for a third consecutive season (and beyond) above that mark.

To calculate a team’s CBT ledger, the league takes the sum of the average annual values of each contract on the books in a season- not the actual payroll in any given year. For the Mets, that figure comes in just under $197MM in 2021, in the estimation of Cot’s Baseball Contracts. (Cot’s pegs their actual payroll at approximately $195.4MM). If Cohen is unwilling to go beyond the first threshold, that’d leave New York a little more than $13MM in CBT space for midseason upgrades.

Cohen didn’t explicitly state he’d be unwilling to push the team’s CBT ledger north of $210MM. Rather, he implied that it’d take one (or more) marquee additions for him to deem that worthwhile, based on the belief that the cost of higher potential penalties in future seasons would outweigh the value of making more marginal upgrades. Of course, that assumes the current luxury tax system will remain in the next CBA, which is up for negotiation this winter. The Mets did not exceed the threshold last season under the previous ownership group, so they’d be subject to the first-time payor penalty if they were to do so this year.

New York’s owner also addressed the contractual status of starters Jacob deGrom and Marcus Stroman. Cohen confirmed the club engaged in preliminary extension discussions with deGrom in Spring Training. Those were never expected to persist into the summer, though, and Cohen indeed shot down the possibility of in-season negotiations. “I’m focused on this year,” he said. “I don’t think it’s the right moment (for extension talks). We’re focused on this year, so obviously it’s something we’re thinking about. We love Jacob.” deGrom is under contract through 2024, but his deal affords him the opportunity to opt out at the end of next season.

Cohen also suggested it was unlikely the Mets would discuss an extension with Stroman during the year. The 30-year-old returned to Queens on an $18.9MM qualifying offer over the winter, and he’s since worked to a stellar 2.34 ERA/3.66 SIERA across 84 2/3 innings. Stroman will hit free agency again next offseason, and the CBA prevents the Mets from tagging with a QO this time around.

Mets Select Jerad Eickhoff, Designate Mason Williams

By | at

The Mets have selected the contract of right-hander Jerad Eickhoff.  Outfielder Mason Williams was designated for assignment to create space on the 26-man and 40-man rosters.

Eickhoff signed a minor league deal in December that will now pay him $1.5MM for reaching the big league roster.  The righty (who turns 31 in July) has spent his entire MLB career in the NL East, having pitched with the Phillies from 2015-19 and initially looking like he could be a solid member of the rotation.  Injuries overshadowed Eickhoff’s last three years in Philadelphia, however, and after being cut loose by the team, he inked minors contracts with the Padres and Rangers in 2020 but didn’t see any big league action.

After a doubleheader against the Nationals yesterday and another doubleheader set for Monday against the Braves, the Mets will give Eickhoff a quick opportunity to take the ball.  Eickhoff could receive a start in one of Monday’s two games, unless he is needed to relief duty in today’s game against Washington.  Since New York has yet another doubleheader coming up on Friday against the Phillies, Eickhoff might find himself in line for another outing over that weekend series against his old team.  Joey Lucchesi just went on the 10-day IL, leaving the Mets a little shorthanded for pitching depth during this busy week.

Williams hit .212/.297/.333 in 37 plate appearances after his contract was selected by New York in late May.  Once a top prospect coming up in the Yankees’ farm system, Williams has only played sparingly over parts of seven MLB seasons with the Yankees, Reds, Orioles, and this year’s action with the Mets.

Mets Place Joey Lucchesi On 10-Day IL, Activate Albert Almora

By | at

The Mets have placed lefty Joey Lucchesi on the 10-day injured list due to inflammation in his throwing elbow.  Outfielder Albert Almora will take Lucchesi’s spot on the active roster, as Almora has himself been activated off the 10-day IL.

With New York facing a number of injuries in its pitching staff this season, Lucchesi has been a valuable arm, able to work both in the rotation and out of the bullpen.  Lucchesi has a 4.46 ERA/3.72 SIERA over 38 1/3 innings (starting eight of his 11 games), and an above-average 26.1% strikeout rate and seven percent walk rate.  The southpaw added to this resume with a strong outing just last night, tossing 5 1/3 shutout innings against the Nationals.

The Mets have doubleheaders scheduled for today, Monday, and on Friday, so the rotation was already facing a crunch even before Lucchesi hit the IL (the club does have an off-day on Thursday to act as something of a reset).  Robert Gsellman is scheduled to start the second game tonight, and a solid outing could put him in line to act as Lucchesi’s replacement.

Almora has been on the IL since May 12 due to a shoulder contusion suffered after a big collision with the outfield wall.  The 27-year-old will settle back into his backup outfield role, and look to essentially restart his season after hitting only .048/.091/.048 in his first 22 plate appearances.

Blue Jays Acquire Jacob Barnes From Mets For Troy Miller

By | at

The Blue Jays have acquired right-hander Jacob Barnes from the Mets for fellow righty Troy Miller, per Anthony DiComo of MLB.com (via Twitter). The Mets only recently designated Barnes for assignment.

Barnes doesn’t have an arsenal with much versatility, relying mostly on a 94.4 mph fastball and 88.9 mph cutter. No matter the pitch mix, Barnes could not avoid the long ball in his 18 2/3 innings with the Mets this season, serving up six long balls and a 25.0 percent home-run-to-fly-ball rate. A 12.5 percent barrel rate was by far the highest of his career.

He did a decent job of limiting free passes (6.3 percent walk rate) and keeping the ball out of the air (49.1 percent groundball rate), but it wasn’t enough to stem the tide. The 31-year-old leaves New York with a 7.27 ERA/6.22 FIP, though a 4.29 xFIP gives at least some indication that he’s been the recipient of tough luck this season.

Miller is a University of Michigan alum who signed as an non-drafted free agent with the Blue Jays in 2018. The 24-year-old began the year at High-A, earning a promotion after three starts with a 1.84 ERA. With Double-A New Hampshire, Miller has tossed 20 innings with a 7.20 ERA.

NL East Notes: Mets, deGrom, McNeil, Nationals, Strasburg, Scherzer

By | at

Jacob deGrom appears on target to make his regularly-scheduled start on Monday, per MLB.com’s Anthony DiComo (via Twitter). DeGrom threw his second bullpen session without incident. Though the Mets haven’t set anything in stone, the unofficial best pitcher on the planet should take the hill against the Braves two days from now.

Jeff McNeil is likely to join deGrom on the diamond on Monday, per Tim Healey of Newsday (via Twitter). McNeil has been out with a hamstring strain since May 16th. McNeil was hitting .242/.336/.374 when he went on the injured list. Though still six percent better than average with the bat, that’s a far cry from McNeil’s usual production. He owned a 139 wRC+ across 1,024 plate appearances coming into the season. In the other dugout today…

  • The Nationals have some updates on their own star hurlers. Stephen Strasburg was playing catch in the outfield today – a small, but positive step in the right direction. There remains no timetable for Strasburg’s return.
  • Max Scherzer, however, will throw a bullpen session later today and potentially return to the rotation on Tuesday in Philadelphia, per Mark Zuckerman of MASNsports.com (via Twitter). The Nats rotation has held up surprisingly well in Scherzer’s absence: They’ve posted a 0.78 team ERA since Scherzer exited his latest start after just two hitters. Should he remain on track and return Tuesday, however, he’ll no doubt provide a boost to the surging Nats, winners of five in a row.  [UPDATE: Scherzer told Zuckerman and other reporters that he is “all good” for Tuesday’s start.]
  • Two years ago on this date, Gerardo Parra walked to the plate to “Baby Shark” for the first time, sparking a trend that would enliven Nats fans for the entirety of their magical 2019 campaign. Parra might soon bring his act back to Washington, per Jesse Dougherty of the Washington Post (Twitter notes). The 11-year veteran has a .222/.385/.333 line in 91 plate appearances for the Nats Triple-A club this season.

Quick Hits: Rays, Glasnow, Roe, Tigers, Boyd, Mets/Nats

By | at

Rays fans can allow themselves some tempered excitement after the latest check-up on Tyler Glasnow. The lanky flamethrower will be shut down for four weeks before beginning to throw again, but that said, they may have located another source of Glasnow’s discomfort, per Marc Topkin of the Tampa Bay Times (via Twitter). The latest diagnosis theorizes that his elbow irritation could at least in part be the result of a bone issue, which Glasnow’s doctors will attempt to treat during this period of rest. Of course, much uncertainty remains for Glasnow, whose injury became a bit of a firestarter for the debate around the use of illegal substances. After his injury, Glasnow was vocal in opposition of MLB’s attempt to curtail the use of illegal substances on the mound by way of an in-season mandate.

Neither Glasnow’s injury nor the “sticky stuff” saga will be resolved in the immediate future, however, so let’s turn instead to the latest news on his Tampa teammate: reliever Chaz Roe has cut his rehab short for the time being. Roe has been out since April with a shoulder strain. The latest issue, however, is not with the shoulder, but rather a case of biceps tendinitis, per Marc Topkin of the Tampa Bay Times (Twitter links). It will be another 7-10 days until he’s able to resume throwing.

Elsewhere around the game…

  • Tigers starter Matthew Boyd has been to see a “number of doctors” about the arm discomfort that landed him on the injured list on June 15th. He won’t pitch again before the All-Star break, but there is no structural damage in the arm, per the Athletic’s Cody Stavenhagen (via Twitter). Detroit plans to be cautious with the 30-year-old southpaw, adds Evan Woodbery of the Mlive Media Group (via Twitter). In 13 starts this season, Boyd has a 3.44 ERA/3.75 FIP across 70 2/3 innings. In terms of the positive, his 6.4 percent walk rate is better than his career norm. On the other side, Boyd’s strikeouts are down (18.8 percent strikeout rate). If all goes well, the Tigers hope to have a healthy Boyd back in the rotation for the second half.
  • The Mets and Nationals will play a doubleheader today. Both teams will add a 27th man to the roster for the day. In the Nationals’ case, right-hander Ryne Harper has stayed with the team after being optioned to Triple-A yesterday, per the team. He will be available out of the pen for manager Davey Martinez in both games. The Mets, meanwhile, recalled right-hander Yennsy Diaz to be their 27th man, per Anthony DiComo of MLB.com (via Twitter). There was some indication that Albert Almora Jr. would be activated from the injured list, and that’s still a possibility for game two, Dicomo notes.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top